[1] |
ZHANG Yanni, DUAN Yuxin, BAI Yi, YU Jinyao, SUN Jiayi, WANG Zejie, LI Ling, YE Qifa.
Novel mechanisms driving renal tubulointerstitial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 348-353.
|
[2] |
LIU Lijing, QIAN Hong, MENG Qingxin, ZHANG Xiang, HE Bin, HE Jianbin, WEI Yingmin.
Sinomenine inhibits oxidative stress and pulmonary fibrosis by activating the Keap1/Nrf2 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 979-987.
|
[3] |
XU Yiqi, WU Qian, LIU Shu, LIU Fan, XING Chunyan, LI Qin, HE Junjun, HE Chunling, ZHAO Yongli, GAO Jialin.
Clinical efficacy and anti-inflammation/anti-fibrosis effect of tripterygium glycosides in the treatment of diabetic nephropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1034-1042.
|
[4] |
LI Yating, YUE Hongmei, LIU Miaomiao, XU Jinhui, WU Xingdong, ZHU Haobin.
The possibility of phosphodiesterase 4 inhibitors as drug therapy for idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 818-823.
|
[5] |
WANG Donghui, JIANG Suwen, HU Airong, ZHU Bo, HE Zheyun, ZHANG Lukan, WANG Jialan, FAN Ying, LIN Ken .
Mulberry exerts antioxidant stress effect in rats with nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 609-616.
|
[6] |
ZHANG Wei, LIU Lei, GUAN Shaoyang, SHENG Zhao, SUN Wenwen.
Analysis of the diagnostic value of fine-needle aspiration cytology and BRAF and RAS gene mutation screening for thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 653-657.
|
[7] |
NING Sisi, ZHAO Yuhong, YAN Lei, TANG Minna, ZHANG Ningzhi, ZHANG Yongqiao, CUI Zhaoqiang.
Controversies over the targets of controlling blood pressure in hyper- tensive patients with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 463-467.
|
[8] |
BAI Jia, YANG Hong, LI Lingling, ZHANG Yangyang, YANG Ying, LV Haihong.
Study on the effect of vitamin D on diabetic neuropathy through mitochondrial/autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 214-219.
|
[9] |
WANG Zhun, SUN Yuying, HUANG Hanchang.
Research progress on the treatment of Alzheimer's disease based on the target of mammalian target of rapamycin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1378-1390.
|
[10] |
ZHU Haobin, YUE Hongmei, WU Xingdong, LIU Miaomiao, LI Yating, XU Jinhui.
Research progress on the role of the Nrf2 signaling pathway in the complications associated with obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1283-1291.
|
[11] |
YANG Zhian, ZHAO Yan, HE Yao, LIU Weiying, YU Qin.
Pyroptosis mediated renal injury caused by chronic intermittent hypoxia and the intervention effect of edaravone in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 10-18.
|
[12] |
WANG Shuang, LIU jia, ZHANG Yueli.
Associations of POR*28 polymorphisms with tacrolimus stable dose in Chinese kidney transplantation patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 991-997.
|
[13] |
ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen.
Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
|
[14] |
HUA Haiyan, YAN Jie, QIN Yufen.
Experimental study of schisandrin B attenuates acute myocardial ischemia injury in rats by inhibiting cardiomyocyte apoptosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 848-856.
|
[15] |
WANG Jinhuo, GAO Xinyue, GUO Jianrong.
Effect of COX-2 inhibitors on postoperative delirium in elderly patients undergoing orthopedic surgery and its possible mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 863-869.
|